Doxorubicin
Showing 1 - 25 of 2,696
Advanced Soft-tissue Sarcoma Trial (LB-100 plus Doxorrubicin, Doxorubicin)
Not yet recruiting
- Advanced Soft-tissue Sarcoma
- LB-100 plus Doxorrubicin
- Doxorubicin
- (no location specified)
Apr 11, 2023
Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance
Not yet recruiting
- Metastatic Leiomyosarcoma
- +5 more
- Computed Tomography
- +3 more
- (no location specified)
Feb 2, 2023
Breast Cancer With Liposomal Doxorubicin Regimen
Recruiting
- Breast Cancer
- +4 more
- Liposomal doxorubicin containing regimen
-
Hangzhou, Zhejiang, ChinaSecond Affiliate Hospital of Zhejiang University
Feb 7, 2023
Solid Tumor, KRAS Mutation-Related Tumors Trial in Washington (NEROFE, Doxorubicin)
Recruiting
- Solid Tumor
- KRAS Mutation-Related Tumors
- NEROFE
- Doxorubicin
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Jan 23, 2023
Relapsed Sarcomas Trial in Cleveland (Disulfiram, Copper Gluconate, Liposomal Doxorubicin (Doxil))
Not yet recruiting
- Relapsed Sarcomas
- Disulfiram
- +2 more
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Apr 18, 2022
Basal Cell Carcinoma Trial in Aventura (Placebo-containing MNA, 25 µg doxorubicin-containing MNA, 50 µg doxorubicin-containing
Terminated
- Basal Cell Carcinoma
- Placebo-containing MNA
- +4 more
-
Aventura, FloridaThe Center for Clinical and Cosmetic Research
Aug 16, 2022
Metastatic Soft Tissue Sarcoma, Advanced Soft Tissue Sarcoma Trial in Aurora (doxorubicin with AGEN1884 and AGEN2034)
Recruiting
- Metastatic Soft Tissue Sarcoma
- Advanced Soft Tissue Sarcoma
- doxorubicin with AGEN1884 and AGEN2034
-
Aurora, ColoradoUniversity of Colorado Hospital
Jan 4, 2023
Metastatic Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma Trial in Hannover (Durvalumab and Tremelimumab,
Completed
- Metastatic Adult Soft Tissue Sarcoma
- Recurrent Adult Soft Tissue Sarcoma
- Durvalumab and Tremelimumab
- Doxorubicin
-
Hannover, GermanyMedizinische Hochschule Hannover
Jan 18, 2023
Angiosarcoma Metastatic Trial in Guangzhou (Abraxane combined with liposomal doxorubicin)
Recruiting
- Angiosarcoma Metastatic
- Abraxane combined with liposomal doxorubicin
-
Guangzhou, Guangdong, ChinaXing Zhang
Sep 4, 2022
Desmoid Tumor Trial in GuangZhou (Liposome doxorubicin, Saline Solution)
Recruiting
- Desmoid Tumor
- Liposome doxorubicin
- Saline Solution
-
GuangZhou, Guangdong, ChinaSun Yat-sen University cancer center
Sep 29, 2022
Cutaneous Squamous Cell Carcinoma, Skin Cancers - Squamous Cell Carcinoma Trial in Pittsburgh (Microneedle Array Doxorubicin
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- Skin Cancers - Squamous Cell Carcinoma
- Microneedle Array Doxorubicin (MNA-D)
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Nov 28, 2022
Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma
Active, not recruiting
- Soft Tissue Sarcoma
- Doxil
- Doxorubicin
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jan 25, 2023
Breast Cancer Trial in Seoul (Extracorporeal shock waves)
Recruiting
- Breast Cancer
- Extracorporeal shock waves
-
Seoul, Yangcheon Gu, Korea, Republic ofKiwhan Kim
Oct 25, 2022
Kaposi Sarcoma, HIV-1-infection Trial (Pegylated liposomal doxorubicin, Paclitaxel)
Not yet recruiting
- Kaposi Sarcoma
- HIV-1-infection
- Pegylated liposomal doxorubicin
- Paclitaxel
- (no location specified)
Jan 20, 2023
Colon Cancer Liver Metastasis Trial in United States (Lyso-Thermosensitive Liposomal Doxorubicin, 5% Dextrose Solution,
Terminated
- Colon Cancer Liver Metastasis
- Lyso-Thermosensitive Liposomal Doxorubicin
- +2 more
-
Los Angeles, California
- +3 more
Sep 15, 2022
Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)
Recruiting
- Breast Cancer
- Pegylated liposomal doxorubicin
- +5 more
-
Shanghai, ChinaShanghai Pudong Hospital
Dec 11, 2022
Advanced Sarcoma, Metastatic Sarcoma, Soft Tissue Sarcoma Trial (YH001, Envafolimab, Doxorubicin)
Recruiting
- Advanced Sarcoma
- +2 more
- YH001
- +2 more
-
Santa Monica, CaliforniaSarcoma Oncology Center
Dec 5, 2022
Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,
Recruiting
- Metastatic Kidney Medullary Carcinoma
- +4 more
- Doxorubicin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Soft Tissue Sarcoma, Adult, Soft Tissue Sarcoma, Child Trial in Charlotte (Pembrolizumab, Doxorubicin)
Active, not recruiting
- Soft Tissue Sarcoma, Adult
- Soft Tissue Sarcoma, Child
- Pembrolizumab
- Doxorubicin
-
Charlotte, North CarolinaLevine Cancer Institute
Sep 29, 2022
Advanced Malignant Tumors Trial in Shanghai (doxorubicin HCl liposome injection)
Recruiting
- Advanced Malignant Tumors
- doxorubicin hydrochloride liposome injection
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 28, 2022
Breast Cancer Trial in New York (Coenzyme Q10, Coenzyme Q10 Placebo)
Completed
- Breast Cancer
- CoQ10
- +3 more
-
New York, New YorkColumbia University Medical Center
Oct 13, 2022
Cutaneous T Cell Lymphoma Trial in Pittsburgh (Micro needle array-Doxorubicin (MNA-D))
Recruiting
- Cutaneous T Cell Lymphoma
- Micro needle array-Doxorubicin (MNA-D)
-
Pittsburgh, PennsylvaniaUniversity Of Pittsburgh Medical Center
Jun 2, 2022
Brain Tumor Trial in Washington (Exablate, Doxorubicin)
Recruiting
- Brain Tumor
- Exablate
- Doxorubicin
-
Washington, District of ColumbiaChildren's National Medical Center
Jan 4, 2023
Brain Tumor Trial in Toronto (Exablate, Doxorubicin)
Recruiting
- Brain Tumor
- Exablate
- Doxorubicin
-
Toronto, Ontario, CanadaSunnybrook Research Institute
Jan 5, 2023
Mitochondrial dysfUnction:Key Player in Doxorubicin-induced
Not yet recruiting
- Doxorubicin Induced Cardiomyopathy
- +3 more
- 31-MRS at 7 Tesla (T)
-
Utrecht, Netherlands
- +1 more
Feb 7, 2023